Cellular biomolecules (Reactive Oxygen Species targets)

Cellular biomolecules, including lipids, proteins, and nucleic acids, serve as the primary substrates for oxidative damage induced by reactive oxygen species (ROS) in photodynamic therapy (PDT) (Source: National Cancer Institute). This process is initiated when a photosensitizing drug is activated by specific wavelengths of light, leading to the production of singlet oxygen (Type II reaction) or free radicals (Type I reaction) (Source: PubChem). These highly reactive species cause irreversible damage to cellular structures such as the plasma membrane, mitochondria, and lysosomes, disrupting cellular homeostasis and signaling (Source: PubMed, PMID: 21663182). Proteins are targeted through the oxidation of amino acid side chains, while lipids undergo peroxidation, leading to membrane rupture and loss of organelle function (Source: StatPearls). DNA damage, particularly the formation of 8-oxoguanine, can also occur, although it is often a secondary effect in PDT-induced cell death (Source: PubMed, PMID: 11070183). The resulting cytotoxic effect is utilized clinically to destroy malignant tumors, treat dermatological conditions like actinic keratosis, and manage vascular diseases such as age-related macular degeneration (Source: FDA). Drugs like porfimer sodium and verteporfin are designed to localize in target tissues, but the non-specific nature of ROS damage requires precise light delivery to minimize off-target phototoxicity (Source: NIH).

Other names

Reactive oxygen species targetsSinglet oxygen substratesPDT molecular targetsOxidative stress substratesPhotodynamic therapy targets

Generation of singlet oxygen and other reactive oxygen species via Type I and Type II photochemical reactions, leading to non-specific oxidative damage of cellular components.